The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
they gave them these uh drugs these sglt2 Inhibitors and it's a pill you can take they're used for diabetes they block this this this protein sglt2 in the kidney that is necessary for glucose to be reabsorbed into the blood and so basically what happens you pee out about like 90 grams of glucose a day but you don't know that you're doing that and that causes you to lose energy
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
if you look at the trials are actually quite consistent you actually get a huge huge protective effect from the sglt2 that is for the first time in like decades we have a drug that actually protects against kidney disease so reduce the risk of kidney disease by about 25% and reduce the risk of heart disease which we've never seen before in any class of anti-diabetic drug
so when you enhance that glycosuria with sglt2 s guess what you actually have a protective like a hugely protective effect because that's the protective mechanism against the root cause